0001662252-16-000299.txt : 20161223
0001662252-16-000299.hdr.sgml : 20161223
20161223135851
ACCESSION NUMBER: 0001662252-16-000299
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161220
FILED AS OF DATE: 20161223
DATE AS OF CHANGE: 20161223
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xenetic Biosciences, Inc.
CENTRAL INDEX KEY: 0001534525
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 452952962
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 99 HAYDEN AVENUE, SUITE 230
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-778-7720
MAIL ADDRESS:
STREET 1: 99 HAYDEN AVENUE, SUITE 230
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: General Sales & Leasing, Inc.
DATE OF NAME CHANGE: 20130227
FORMER COMPANY:
FORMER CONFORMED NAME: GENERAL AIRCRAFT INC.
DATE OF NAME CHANGE: 20111108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DEPTULA-HICKS DARLENE M
CENTRAL INDEX KEY: 0001089409
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37937
FILM NUMBER: 162068734
MAIL ADDRESS:
STREET 1: C/O ICAD, INC.
STREET 2: 98 SPIT BROOK ROAD, SUITE 100
CITY: NASHUA
STATE: NH
ZIP: 03062
4
1
form4.xml
OWNERSHIP DOCUMENT
X0306
4
2016-12-20
0
0001534525
Xenetic Biosciences, Inc.
XBIO
0001089409
DEPTULA-HICKS DARLENE M
99 HAYDEN AVENUE, SUITE 230
LEXINGTON
MA
02421
1
0
0
0
Stock Option
3.50
2016-12-20
4
A
0
10000
0.00
A
2017-03-20
2026-12-20
Common Stock
10000
31416
D
Stock Option
3.50
2016-12-20
4
A
0
10000
0.00
A
2017-06-20
2026-12-20
Common Stock
10000
41416
D
Stock Option
3.50
2016-12-20
4
A
0
10000
0.00
A
2017-09-20
2026-12-20
Common Stock
10000
51416
D
Stock Option
3.50
2016-12-20
4
A
0
10000
0.00
A
2017-12-20
2026-12-20
Common Stock
10000
61416
D
On December 20, 2016 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the "Plan"). The Reporting Owner has the right to purchase 40,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on December 19, 2016 of $3.50. The Option vests quarterly over twelve months.
/s/ Darlene Deptula-Hicks
2016-12-22